Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-10

Clinical Trial Update: Epinephrine Infusion for Prophylaxis Against Maternal Hypotension During Caesarean Section [Phase 4]

View source ↗

Summary

Phase 4 trial update on epinephrine infusion to prevent maternal hypotension during cesarean section has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epinephrine infusion (epinephrine)

Snippet

Sponsor: Kasr El Aini Hospital | Conditions: Post-spinal Hypotension, Cesarean Section | Phase 4 | Status: TERMINATED